Exagen (XGN) Operating Expenses (2018 - 2026)

Exagen (XGN) has reported Operating Expenses for 9 consecutive years, with $13.6 million the latest figure, recorded in Q1 2026.

• Operating Expenses for Q1 2026 came in at $13.6 million, up 9.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.0 million (up 13.36% YoY), and the FY2025 annual result was $52.9 million, up 13.09% from the prior year.
• Operating Expenses was $13.6 million for Q1 2026 at Exagen, down from $14.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $27.3 million in Q4 2022 and troughed at -$4.2 million in Q4 2023.
• Average Operating Expenses over 5 years is $15.1 million, with a median of $13.6 million recorded in 2026.
• Year-over-year, Operating Expenses plunged 115.3% in 2023 and jumped 383.73% in 2024.
• Over 5 years, Operating Expenses stood at $27.3 million in 2022, then sank by 115.3% to -$4.2 million in 2023, then surged by 383.73% to $11.9 million in 2024, then rose by 19.57% to $14.2 million in 2025, then decreased by 3.96% to $13.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $13.6 million in Q1 2026, $14.2 million in Q4 2025, and $13.2 million in Q3 2025.